Fecal Calprotectin During Treatment of Severe Infantile Colic With Lactobacillus reuteri DSM 17938: A Randomized, Double-Blind, Placebo-Controlled Trial

  • Savino F
  • De Marco A
  • Ceratto S
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Fecal calprotectin level has been reported to correlate with inflammation in inflammatory bowel disease in adults, and recently its relationship with infantile colic has also been described. Fecal calprotectin is elevated in infants with hematochezia and possible allergic colitis. The objectives were to evaluate fecal calprotectin at the time of enrollment and its variation after 3 weeks of therapy with a probiotic ( Lactobacillus reuteri DSM 17938) in infants with severe infantile colic admitted to our hospital for either hematochezia, …

Cite

CITATION STYLE

APA

Savino, F., De Marco, A., Ceratto, S., & Mostert, M. (2015). Fecal Calprotectin During Treatment of Severe Infantile Colic With Lactobacillus reuteri DSM 17938: A Randomized, Double-Blind, Placebo-Controlled Trial. Pediatrics, 135(Supplement_1), S5–S6. https://doi.org/10.1542/peds.2014-3330h

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free